
CAS 119567-79-2: Viramidine
Formula:C8H13N5O4
InChI:InChI=1S/C8H13N5O4/c9-6(10)7-11-2-13(12-7)8-5(16)4(15)3(1-14)17-8/h2-5,8,14-16H,1H2,(H3,9,10)/t3-,4-,5-,8-/m1/s1
InChI key:InChIKey=NHKZSTHOYNWEEZ-AFCXAGJDSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2N=C(C(=N)N)N=C2
Synonyms:- 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboximidamide
- 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboximidine
- 1-β-<span class="text-smallcaps">D</span>-Ribofuranosyl-1H-1,2,4-triazole-3-carboximidamide
- 1H-1,2,4-Triazole-3-carboximidamide, 1-beta-D-ribofuranosyl-
- 1H-1,2,4-Triazole-3-carboximidamide, 1-β-<span class="text-smallcaps">D</span>-ribofuranosyl-
- Icn 3142
- Ribamidine
- Ribavirin amidine
- Unii-R3B1994K2E
- Viramidine
- Taribavirin
- See more synonyms
Sort by
Found 3 products.
1H-1,2,4-Triazole-3-carboximidamide, 1-β-D-ribofuranosyl-
CAS:Formula:C8H13N5O4Molecular weight:243.2199Taribavirin
CAS:Taribavirin: oral drug targeting HCV in liver, spares RBCs to reduce risk of anemia.Formula:C8H13N5O4Purity:98%Color and Shape:SolidMolecular weight:243.22Viramidine
CAS:Viramidine is a nucleotide analogue prodrug, which is derived from naturally occurring nucleosides, specifically optimized for enhanced therapeutic profiles. Its mode of action involves conversion into ribavirin triphosphate within the body. This active form inhibits viral RNA polymerase, a critical enzyme necessary for viral replication. By disrupting the synthesis of viral RNA, Viramidine effectively reduces viral proliferation within host cells. Primarily, Viramidine is investigated and utilized in the context of antiviral treatments, especially for hepatitis C virus (HCV). It serves as an alternative to ribavirin, aiming to maintain efficacy while reducing the associated hemolytic anemia observed in ribavirin use. Viramidine's design allows for targeted liver delivery, enhancing its antiviral effectiveness and minimizing systemic exposure. The research focus on Viramidine highlights its potential in improving the therapeutic index of conventional ribavirin by offering a more hepatic-selective approach. Scientists continue to explore its pharmacokinetics and dynamics to optimize clinical outcomes in antiviral regimens.Purity:Min. 95%